HUMANIGEN, INC Business Operations Contracts & Agreements
11 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Development Agreements (1)
- Sales Agreements (1)
- Services Agreements (2)
- Settlement Agreements (1)
- Supply Agreements (1)
- Termination Agreements (4)
- Settlement Agreement dated as of December 16, 2022, by and between the Registrant and Catalent Pharma Solutions, LLC (Filed With SEC on March 30, 2023)
- Amended and Restated Cooperative Research and Development Agreement, dated as of January 21, 2021, by and among the Registrant, Joint Program Executive Office for Chemical,... (Filed With SEC on March 10, 2021)
- Master Services Agreement effective as of January 8, 2021 between Humanigen, Inc. and EVERSANA Life Science Services, LLC (Filed With SEC on January 14, 2021)
- Controlled Equity OfferingSM Sales Agreement, dated December 31, 2020, by and between the Company and Cantor Fitzgerald & Co (Filed With SEC on December 31, 2020)
- Clinical Collaboration Agreement, dated May 30, 2019 between the Registrant and Kite Pharma, Inc (Filed With SEC on August 13, 2019)
- Termination and Release Agreement, dated February 27, 2018, between the Registrant and Black Horse Capital Master Fund, Black Horse Capital, Cheval Holdings, Ltd., and Nomis Bay... (Filed With SEC on May 8, 2018)
- SERVICES AGREEMENT (Filed With SEC on December 9, 2015)
- TERMINATION AGREEMENT (Filed With SEC on May 11, 2015)
- TERMINATION AGREEMENT (Filed With SEC on November 6, 2014)
- KALOBIOS PHARMACEUTICALS, INC. TERMINATION AGREEMENT AND WAIVER (Filed With SEC on October 12, 2012)
- CONFIDENTIAL TREATMENT REQUESTED SUPPLY AGREEMENT KB001-A bulk (Filed With SEC on October 5, 2012)
